Suppr超能文献

相似文献

2
SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners.
Minerva Cardioangiol. 2020 Apr;68(2):61-64. doi: 10.23736/S0026-4725.20.05250-0. Epub 2020 Mar 9.
3
Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA's Mission: Lifeline.
Circulation. 2020 Jul 21;142(3):199-202. doi: 10.1161/CIRCULATIONAHA.120.048180. Epub 2020 May 2.
4
Crucial Conversations With Patients in the Era of COVID-19.
Circulation. 2020 Jul 21;142(3):191-193. doi: 10.1161/CIRCULATIONAHA.120.047374. Epub 2020 May 6.
5
The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.
J Am Heart Assoc. 2020 Sep 15;9(18):e018274. doi: 10.1161/JAHA.120.018274. Epub 2020 Jul 27.
6
[What I talk about when I talk about COVID-19].
Laeknabladid. 2020 Sep;106(9):395. doi: 10.17992/lbl.2020.09.594.
7
Forced Choices: Ethical Challenges in Cardiology During the COVID-19 Pandemic.
Circulation. 2020 Jul 21;142(3):194-196. doi: 10.1161/CIRCULATIONAHA.120.047681. Epub 2020 May 11.
9
Rules for scientific progress while living with the COVID-19 Pandemic: from 'benchside' to 'fireside.'.
Cancer Biol Ther. 2020 Jul 2;21(7):581-582. doi: 10.1080/15384047.2020.1747775. Epub 2020 Mar 30.

引用本文的文献

1
2
The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis.
Front Cardiovasc Med. 2022 Nov 3;9:1020744. doi: 10.3389/fcvm.2022.1020744. eCollection 2022.
3
Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention.
High Blood Press Cardiovasc Prev. 2022 Mar;29(2):91-102. doi: 10.1007/s40292-021-00503-4. Epub 2022 Jan 13.
4
Repurposing Cardio-Metabolic Drugs to Fight Covid19.
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):419-423. doi: 10.1007/s40292-021-00475-5. Epub 2021 Sep 15.
5
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era.
Front Physiol. 2021 Jul 16;12:643721. doi: 10.3389/fphys.2021.643721. eCollection 2021.
6
Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.
Circ Res. 2021 Apr 2;128(7):1062-1079. doi: 10.1161/CIRCRESAHA.121.318054. Epub 2021 Apr 1.

本文引用的文献

1
Deaths in SARS-Cov-2 Positive Patients in Italy: The Influence of Underlying Health Conditions on Lethality.
Int J Environ Res Public Health. 2020 Jun 21;17(12):4450. doi: 10.3390/ijerph17124450.
3
Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Diabetes Obes Metab. 2020 Oct;22(10):1915-1924. doi: 10.1111/dom.14124. Epub 2020 Jul 16.
4
Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease.
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1409-1417. doi: 10.1016/j.numecd.2020.05.020. Epub 2020 May 30.
5
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.
7
Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.
Heart. 2020 Aug;106(15):1119-1121. doi: 10.1136/heartjnl-2020-317110. Epub 2020 May 25.
8
Cardiovascular Disease Prevention and Implications of Coronavirus Disease 2019: An Evolving Case Study in the Crescent City.
J Am Heart Assoc. 2020 Jul 7;9(13):e016997. doi: 10.1161/JAHA.120.016997. Epub 2020 May 16.
9
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
Eur Heart J. 2020 Jun 7;41(22):2083-2088. doi: 10.1093/eurheartj/ehaa409.
10
Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular Diseases.
Mater Sociomed. 2020 Mar;32(1):71-76. doi: 10.5455/msm.2020.32.71-76.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验